Search Within

Ronak Hasmukh Shah

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (9)
Groups
  1. Department of Medicine (19)
  2. Gastrointestinal Oncology Service (19)
  3. Solid Tumor Oncology Division (19)
  4. Department of Pathology and Laboratory Medicine (18)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  6. GSK Faculty (17)

More Groups

People
  1. Michael Berger (17)
  2. David Solit (10)
  3. Diane Reidy (8)
  4. Joanne Chou (7)
  5. Nitya Raj (7)
  6. Andrea Cercek Hanjis (6)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (2)
  4. 2020 (1)
  5. 2018 (2)
  6. 2017 (6)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. JCO Precision Oncology (2)
  3. Cancer (1)
  4. Clinical Cancer Research (1)
  5. Endocrine-Related Cancer (1)
  6. Genome Biology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. American Medical Association (1)
  5. Biomed Central Ltd (1)
  6. Bioscientifica Ltd (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms
    Journal Article

    Cowzer, D.; Shah, R. H.; Chou, J. F.; Kundra, R.; Punn, S.; Fiedler, L.; DeMore, A.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; more...
    Endocrine-Related Cancer (2024)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
    Journal Article

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Murphy, J. J.; Cleary, J. M.; Shapiro, G. I.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
    Meeting Abstract

    Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial
    Meeting Abstract

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Cleary, J. M.; Quinn, D. I.; Brana, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • MSI detection in plasma cfDNA: MSI as a marker of disease burden
    Meeting Abstract

    Srinivasan, P.; Latham, A.; Patel, Z.; Ziegler, J.; Hasan, M.; Patel, J. A.; Johnson, I.; Shah, R.; Meng, F.; Jing, X.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Widespread somatic loss of heterozygosity as a possible marker of disease aggressiveness in metastatic well differentiated pancreatic neuroendocrine tumors
    Meeting Abstract

    Akala, O. O.; Shah, R.; Untch, B. R.; Kelly, V.; Chou, J. F.; Ladanyi, M.; Berger, M. F.; Klimstra, D. S.; Reidy, D. L.; Raj, N. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save